Using the cancer cell line and the AOM-DSS model of colitis-associated colon cancer, this group demonstrated that when used with epithelial barrier disruptive agent DSS, F. nucleatum synergistically increased the aggressiveness and EMT characteristics of cancer cells and this process involved EGFR signaling pathways [24]. The gene discussed is EGFR; the disease is cancer.